Open Orphan - New contract win

Cathal Friel, Executive Chairman of Open Orphan plc, a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge clinical trials, provides an update on the signing of a new contract with a top 3 Pharma Company.

Cathal Friel
Executive Chairman

Company Events - OPEN ORPHAN

Open Orphan Presentation

Cathal Friel, CEO

Wed, 9 Oct 2019, 7:00am BST